Our Pricing

Compare Acid Reflux Treatment Options Available

When you compare acid reflux treatment options UK pharmacies offer, understanding the differences between proton pump inhibitors (PPIs) helps you make an informed choice. At Cured Pharmacy, we dispense genuine UK-licensed PPIs from £9.99, with transparent pricing and a free online consultation completed in under three minutes by our UK-registered clinical team.

How Proton Pump Inhibitors Work for Acid Reflux

Proton pump inhibitors remain the gold standard for managing gastro-oesophageal reflux disease (GORD) and persistent heartburn in the UK [1]. These medications work by blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells, reducing stomach acid production by up to 90% within the first dose [1].

Unlike antacids that neutralise existing acid or H2 receptor antagonists that provide temporary relief, PPIs offer sustained acid suppression for 24 hours with once-daily dosing [2]. Clinical trials demonstrate that PPIs heal oesophageal erosions in approximately 80-90% of patients within eight weeks, compared to 50-60% with H2 blockers [2].

The MHRA licenses several PPI options in the UK, each with slightly different pharmacokinetic profiles but similar clinical efficacy. Your prescriber will consider factors including symptom severity, previous treatment response, concurrent medications, and cost when recommending the most appropriate option for your circumstances.

Omeprazole: The Original PPI Option

Omeprazole was the first proton pump inhibitor introduced to the UK market and remains one of the most prescribed acid reflux treatments [3]. Available in 10mg and 20mg capsules, omeprazole typically provides symptom relief within 1-2 days, with maximum effect achieved after four days of consecutive use [3].

At Cured Pharmacy, generic omeprazole capsules start from £9.99, making this the most cost-effective PPI option for many patients. We also dispense Losec, the branded version of omeprazole, which some patients prefer due to familiarity or specific formulation requirements.

Clinical studies show omeprazole 20mg once daily heals duodenal ulcers in approximately 90% of patients within four weeks and gastric ulcers in 80% within eight weeks [3]. The standard course lasts four to eight weeks, though some patients require longer-term maintenance therapy under prescriber supervision.

Omeprazole Dosing and Administration

Standard dosing begins at 20mg once daily, taken before breakfast on an empty stomach for optimal absorption. Capsules should be swallowed whole with water—do not chew or crush them, as this compromises the enteric coating designed to protect the active ingredient from stomach acid. Patients who struggle with capsules may open them and mix the contents with fruit juice or yoghurt, though this should be consumed immediately without chewing the granules.

Esomeprazole vs Omeprazole: Understanding the Difference

Esomeprazole is the S-isomer of omeprazole, meaning it contains only the active component of the racemic omeprazole mixture [4]. This molecular refinement provides more predictable pharmacokinetics and slightly higher bioavailability, resulting in more consistent acid suppression across patient populations [4].

Head-to-head trials demonstrate esomeprazole 20mg provides equivalent efficacy to omeprazole 20mg for most indications, with some studies suggesting marginally faster healing rates for erosive oesophagitis [4]. At Cured Pharmacy, esomeprazole 20mg is available from £9.99 for 28 tablets—a modest premium over generic omeprazole that some patients find worthwhile for enhanced consistency.

The clinical significance of choosing esomeprazole over omeprazole remains debated among UK gastroenterologists. For straightforward GORD management, generic omeprazole typically suffices. Patients who experience incomplete symptom control on omeprazole may benefit from switching to esomeprazole or adjusting timing and dosage under prescriber guidance.

Lansoprazole: Fast-Acting Alternative

Lansoprazole offers rapid onset of action, with some patients reporting symptom improvement within hours of the first dose [5]. Available in 15mg and 30mg strengths, lansoprazole capsules dissolve quickly in the stomach, making them suitable for patients requiring swift acid suppression.

We also stock Zoton FasTab, an orally disintegrating lansoprazole formulation that dissolves on the tongue without water. This presentation proves particularly valuable for patients with swallowing difficulties, those experiencing nausea, or individuals requiring medication administration outside typical settings. Zoton FasTab provides identical efficacy to standard lansoprazole capsules with enhanced convenience [5].

Clinical data shows lansoprazole 30mg once daily achieves symptom resolution in approximately 85% of GORD patients within four weeks [5]. The 15mg strength serves as an effective maintenance dose for patients who have achieved initial healing, reducing the risk of symptom recurrence whilst minimising long-term PPI exposure.

Lansoprazole for Helicobacter Pylori Eradication

Lansoprazole plays a crucial role in triple therapy regimens for Helicobacter pylori eradication, typically prescribed at 30mg twice daily alongside two antibiotics for seven days. The elevated gastric pH created by lansoprazole enhances antibiotic efficacy and promotes ulcer healing. UK prescribers commonly use lansoprazole-based eradication therapy as first-line treatment for H. pylori-associated peptic ulcers, achieving eradication rates exceeding 80% when patient adherence is maintained [5].

Pantoprazole: Long-Acting Gastro-Resistant Option

Pantoprazole distinguishes itself through prolonged acid suppression and excellent tolerability profile [6]. The gastro-resistant tablet formulation protects the active ingredient until it reaches the small intestine, where absorption occurs efficiently regardless of meal timing—though taking pantoprazole before breakfast remains the standard recommendation.

Available in 20mg and 40mg strengths at Cured Pharmacy from £9.99, pantoprazole demonstrates particular value for patients requiring long-term acid suppression or those who have experienced adverse effects with other PPIs. Clinical trials report lower rates of headache and gastrointestinal disturbance with pantoprazole compared to some alternative PPIs [6].

Pantoprazole 40mg once daily provides comparable efficacy to other standard-dose PPIs for healing erosive oesophagitis and managing GORD symptoms [6]. The 20mg strength serves as an effective maintenance option, and some patients find once-daily pantoprazole provides more consistent 24-hour symptom control compared to shorter-acting alternatives.

Choosing the Right Acid Reflux Treatment

Selecting the optimal PPI involves balancing clinical efficacy, tolerability, convenience, and cost. For most patients with uncomplicated GORD, generic omeprazole provides excellent symptom control at the lowest price point. Those requiring faster onset may prefer lansoprazole, whilst patients seeking enhanced consistency might opt for esomeprazole or the prolonged action of pantoprazole.

Brand-name options including Losec (omeprazole), Nexium (esomeprazole), and Zoton FasTab (lansoprazole) offer identical active ingredients to generic equivalents but may include different inactive excipients or delivery mechanisms. Some patients report preferring branded formulations due to familiarity or perceived differences in tolerability, though clinical evidence suggests bioequivalence with properly manufactured generics.

Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), and the UK prescriber team assess your medical history, current medications, symptom pattern, and previous treatment responses during the free online consultation. This personalised approach ensures you receive the most appropriate PPI for your specific circumstances, with transparent pricing displayed before you complete the assessment. All treatments require clinical approval by a UK-registered prescriber and are dispensed as genuine UK-licensed medicines with discreet packaging and reliable delivery.

When to Consider Switching PPIs

Approximately 10-15% of patients experience inadequate symptom control on standard-dose PPI therapy [2]. Before concluding treatment failure, prescribers typically verify correct dosing timing (30-60 minutes before breakfast), assess adherence, and exclude other contributing factors such as dietary triggers or concurrent NSAID use. If symptoms persist despite optimised omeprazole therapy, switching to an alternative PPI such as esomeprazole, lansoprazole, or pantoprazole may provide improved control. Some patients metabolise certain PPIs more rapidly due to genetic variations in CYP2C19 enzyme activity, making therapeutic switching a valuable strategy when initial treatment proves insufficient.

Scientific References

1. Shin, J. M., & Kim, N. (2013). Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. Journal of Neurogastroenterology and Motility, 19(1), 25-35. https://doi.org/10.5056/jnm.2013.19.1.25
2. Katz, P. O., Gerson, L. B., & Vela, M. F. (2013). Guidelines for the diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology, 108(3), 308-328. https://doi.org/10.1038/ajg.2012.444
3. Howden, C. W., & Burget, D. W. (2020). Efficacy and safety of omeprazole in the treatment of gastroesophageal reflux disease. Therapeutic Advances in Gastroenterology, 13, 1756284820925266. https://doi.org/10.1177/1756284820925266
4. Kirchheiner, J., et al. (2009). Esomeprazole and omeprazole: comparison of the enantiomers' inhibition of gastric acid secretion. Clinical Pharmacology & Therapeutics, 85(5), 527-533. https://doi.org/10.1038/clpt.2008.292
5. Stedman, C. A., & Barclay, M. L. (2000). Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963-978. https://doi.org/10.1046/j.1365-2036.2000.00788.x
6. Blume, H., et al. (2006). Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update. Drug Safety, 29(9), 769-784. https://doi.org/10.2165/00002018-200629090-00002

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.